NCIM Training - Mistletoe Therapy in Practice

Two-Day Mistletoe Training - NCIM - National Centre for Integrative Medicine

REGISTER

Who should attend

  • Medical doctors (GPs, oncologists, palliative care physicians, integrative medicine practitioners)
  • Oncology and palliative care nurses
  • Hospital pharmacists and clinical pharmacists
  • Allied health professionals working in cancer care
  • Healthcare practitioners seeking to expand their Integrative Medicine knowledge

Additional Information:

In the UK, Mistletoe Therapy is only available with a private prescription from a GMC registered doctor.

Prerequisites:

Attendees should have a foundational understanding of oncology or experience working with cancer patients.

What you will learn

By the end of this two-day training, participants will be able to:

Day 1: Foundations and Preparation 

  • Understand the historical development and anthroposophical principles underlying mistletoe therapy
  • Describe the manufacturing processes of different mistletoe preparations (fermented vs. non-fermented)
  • Identify the major mistletoe products available in the UK and Europe (Iscador,
  • Helixor, Abnoba-viscum, etc.) and their distinguishing characteristics
  • Explain the differences between host tree species and their clinical application
  • Review the pharmacological properties and proposed mechanisms of action
  • Understand quality control, storage, and handling requirements

Day 2: Clinical Application and Evidence

  • Apply dosing protocols and administration techniques for subcutaneous injection
  • Develop treatment plans for patients with different cancer types
  • Recognise and manage common side effects and contraindications
  • Explore mistletoe use beyond oncology, including applications in Chronic Fatigue Syndrome/ME and immune modulation
  • Analyse real-world case studies and treatment outcomes
  • Critically appraise the current research evidence base
  • Participate in the Research and Evaluation Workshop with Professor Gene Feder, examining study design, clinical trials, and future research directions